Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Stay informed with the Divis Labs Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...

Divi’s Laboratories shares gained over 3 per cent as analysts flagged 2026 as a potential inflection point, driven by a ...

Vinay Rajani of HDFC Securities says Divis Labs share price has broken out from the box pattern on the daily chart with the ...

India's share in global CRDMO market will likely rise to 4.7% by 2029 from 3.8% in 2024, making it an attractive sector, HDFC ...

Shares of Divis Laboratories rose 3 percent to Rs 6,188 on Friday, August 22, after global brokerage Citi turned upbeat on the stock, flagging attractive valuations and sector tailwinds. Citi ...

Earnings call Divi’s Laboratories reported Q2 FY25 consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose to ₹510 crore, up 46.6% YoY. Custom synthesis now contributes ...

Stock market today: Indian equity indices remained largely unchanged on Wednesday as financial stocks retraced from their near-record peaks, counterbalancing the positive sentiment surrounding a ...

HYDERABAD, India--(BUSINESS WIRE)--Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Divi’s Laboratories (NSE: DIVISLAB), one of the largest active ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey BENGALURU (Reuters) - Shares of India's Divi's Laboratories Ltd, which makes the main ingredient of Merck & ...

Earnings call Divi's Laboratories posted a 25.4% YoY revenue growth for Q3 FY25, with PAT rising 64.5% YoY. Custom synthesis continues to drive growth, while backward integration via the new Kakinada ...